Neoadjuvant chemoradiation therapy is beneficial for clinical stage T2 N0 esophageal cancer patients due to inaccurate preoperative staging

Jennifer Q. Zhang, Craig M. Hooker, Malcolm V. Brock, James Shin, Sue Lee, Remealle How, Noreli Franco, Helen Prevas, Alicia Hulbert, Stephen C. Yang

Research output: Contribution to journal › Article › peer-review

51 Scopus citations

Fingerprint

Dive into the research topics of 'Neoadjuvant chemoradiation therapy is beneficial for clinical stage T2 N0 esophageal cancer patients due to inaccurate preoperative staging'. Together they form a unique fingerprint.

Medicine & Life Sciences